VANGUARD GROUP INC 13D and 13G filings for Merck & Co., Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-06 2:08 pm Purchase | 2025-02-28 | 13G | Merck & Co., Inc. MRK | VANGUARD GROUP INC | 253,257,639 10.020% | 8,490,605 (+3.47%) | Filing |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | Merck & Co., Inc. MRK | VANGUARD GROUP INC | 244,767,034 9.660% | 17,561,056 (+7.73%) | Filing |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | Merck & Co., Inc. MRK | VANGUARD GROUP INC | 227,205,978 8.960% | 16,003,447 (+7.58%) | Filing |
| 2022-02-09 3:15 pm Sale | 2021-12-31 | 13G | Merck & Co., Inc. MRK | VANGUARD GROUP INC | 211,202,531 8.360% | -7,211,824 (-3.30%) | Filing |
| 2021-02-10 10:02 am Sale | 2020-12-31 | 13G | Merck & Co., Inc. MRK | VANGUARD GROUP INC | 218,414,355 8.240% | -2,234,010 (-1.01%) | Filing |